Skip to main content
. 2009 Oct 30;192(1):356–359. doi: 10.1128/JB.01096-09

TABLE 1.

B. subtilis mutant strains

Strain Genotypea Reference
SSB1044 mrnC::pMUTIN2 (mrnC::ery) 15
SSB1030 pnp::cm 17
BG457 rph::spc 14
BG393b rph::cm rnr::spc 17
BG395b rph::cm yhaM::pm 17
BG396 rph::cm rnr::spc yhaM::pm 1
BG508c pnp::kan rph::spc rnr::tc 1
CCB084 amyE::pCT1[Pxyl-rnjA] Cm rnjA::spc 2
CCB166 mrnC::ery amyE::pCT1[Pxyl-rnjA] Cm rnjA::spc This work
CCB167 mrnC::ery pnp::cm This work
CCB168 mrnC::ery rnr::spc This work
CCB169 mrnC::ery rph::spc This work
CCB170 mrnC::ery yhaM::pm This work
CCB225 mrnC::ery yhaM::pm rph::cm This work
CCB171 mrnC::ery rnr::spc rph::cm This work
CCB172 mrnC::ery rnr::spc rph::cm yhaM::pm This work
CCB173 mrnC::ery rnr::spc rph::cm yhaM::pm pnp::kan This work
a

Resistance markers are as follows: ery, erythromycin; cm, chloramphenicol; kan, kanamycin; pm, phleomycin; and spc, spectinomycin.

b

SSB1044 transformants with these DNAs were screened for Cms to obtain CCB168 and CCB170 double mutants only.

c

CCB172 transformants with DNA from strain BG508 were selected for Eryr, Pmr, Kanr, Cmr, Spcr, and Tcs.